Application 206676
- Type
- ANDA
- Sponsor
- BEXIMCO PHARMS USA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CYPROHEPTADINE HYDROCHLORIDE | CYPROHEPTADINE HYDROCHLORIDE | TABLET;ORAL | 4MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 72789-102 | Cyproheptadine Hydrochloride | Cyproheptadine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 72789-102 | Cyproheptadine Hydrochloride | Cyproheptadine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 72789-102 | Cyproheptadine Hydrochloride | Cyproheptadine Hydrochloride | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 76385-130 | Cyproheptadine Hydrochloride | Cyproheptadine Hydrochloride | Bayshore Pharmaceuticals LLC | ANDA | Current |
| 76385-130 | Cyproheptadine Hydrochloride | Cyproheptadine Hydrochloride | Bayshore Pharmaceuticals LLC | ANDA | Current |
| 76385-130 | Cyproheptadine Hydrochloride | Cyproheptadine Hydrochloride | Bayshore Pharmaceuticals LLC | ANDA | Current |